###begin article-title 0
###xml 57 65 <span type="species:ncbi:9606">Patients</span>
MCP-1 -2518 A/G Single Nucleotide Polymorphism in Slovak Patients with Systemic Sclerosis
###end article-title 0
###begin p 1
Recommended by Eric Morand
###end p 1
###begin p 2
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 717 718 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 835 836 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
###xml 548 555 <span type="species:ncbi:9606">patient</span>
###xml 654 662 <span type="species:ncbi:9606">patients</span>
###xml 685 693 <span type="species:ncbi:9606">patients</span>
###xml 804 812 <span type="species:ncbi:9606">patients</span>
Recent study in a group of German patients with SSc has implicated the SNP in the MCP-1 gene (-2518 A to G) as a factor of susceptibility to SSc. Reflecting the need for replication of genetic association studies, we investigated if this SNP is associated with SSc in another Caucasian population. MCP-1 -2518 A/G genotypes were determined using PCR-SSP in 46 SSc patients and in 449 healthy subjects, all unrelated and of Slovak (Slavonic) origin. The distribution of MCP-1 -2518 A/G genotypes complied with the Hardy-Weinberg equilibrium both in patient and healthy control groups. There was no difference in MCP-1 -2518*G allele frequency between SSc patients and healthy subjects (patients: 0.23; controls: 0.24; P > .05). Furthermore, MCP-1 -2518 GG homozygotes were similarly represented among SSc patients and healthy subjects (P > .05). The association of MCP-1 -2518 A/G SNP with SSc observed originally in German population was not replicated in the Slovak population.
###end p 3
###begin title 4
1. INTRODUCTION
###end title 4
###begin p 5
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
Systemic sclerosis (SSc) is a complex autoimmune disease characterised by fibrotic changes in the connective tissues of skin and internal organs [1]. Aetiology of SSc is not clear to date, however, polymorphisms in genes for inflammatory mediators, tissue-matrix proteins, and growth factors have been recently implicated in autoimmune and fibrotic processes in SSc [1-4].
###end p 5
###begin p 6
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
In particular, chemokine (C-C motif) ligand 2 (CCL2) has been identified in circulation and in lesions from SSc patients [5-10]. This chemokine, also known as MCP (monocyte chemoattractant protein)-1, is chemoattractant for monocytes/macrophages and is also an inducer of collagen biosynthesis [1, 10, 11]. It has been, therefore, speculated that MCP-1 upregulation may cause cellular accumulation in SSc lesions [7, 8] and may be also responsible for massive deposition of extracellular matrix proteins in SSc skin [1, 10, 11].
###end p 6
###begin p 7
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
###xml 646 653 <span type="species:ncbi:9606">patient</span>
Recently, a single nucleotide polymorphism (SNP) in the promoter region of the MCP-1 gene (-2518 A/G), whose G variant may associate with increased MCP-1 gene transcriptional activity [12], was investigated in German SSc patients [13]. Overrepresentation of MCP-1 -2518 GG homozygotes among the patients implicated carriage of MCP-1 G allele as a risk factor for SSc [13]. To date, this observation has not, however, been confirmed in other cohorts or populations. In agreement with rules of performing association studies [14], this study aimed at replication of the association between the MCP-1 -2518 A/G SNP and systemic sclerosis in another patient population of Caucasian origin, namely in Slavonic population of Slovakia.
###end p 7
###begin title 8
2. MATERIALS AND METHODS
###end title 8
###begin title 9
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
2.1. Patients and controls
###end title 9
###begin p 10
###xml 70 77 70 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
###xml 180 188 <span type="species:ncbi:9606">patients</span>
###xml 405 413 <span type="species:ncbi:9606">Patients</span>
46 patients with systemic sclerosis (SSc) were included in the study (Table 1). In agreement with fundamental requirements for replication of genetic association studies [14], SSc patients enrolled in the present study were classified, characterised, and subgrouped according to the criteria of American College of Rheumatology [15]; similar approach was applied also in the study under replication [13]. Patients were unrelated individuals of Slovak origin and were recruited in one tertiary referral centre (National Institute of Rheumatic Diseases, Piestany, Slovak Republic). The control population consisted of 449 healthy unrelated volunteers recruited in nearby Bratislava (284 males/165 females, mean age +/- SD, 49 +/- 10 years), in which the absence of any autoimmune disease was excluded by health questionnaire and interview.
###end p 10
###begin p 11
Informed consent for the anonymous usage of their DNA for the purposes of this study was obtained from all enrolled subjects. The study was performed with the approval of relevant ethics committees in National Institute of Rheumatic Diseases, Piestany and Medical Faculties in Bratislava and Olomouc.
###end p 11
###begin title 12
2.2. Assessment of MCP-1 -2518 single nucleotide polymorphism
###end title 12
###begin p 13
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Genomic DNA was extracted from peripheral blood leukocytes by standard salting-out method. SNP MCP-1 -2518 (rs1024611) was genotyped by polymerase chain reaction with sequence specific primers (PCR-SSP) as described elsewhere [16]. Briefly, standard and mutant alleles were amplified in two separate reactions. The constant reverse primer (5' TGA GTG TTC ACA TAG GCT TC 3') was used for amplification with the forward specific primers either for the standard allele A (5' GTG GGA GGC AGA CAG CTA 3') or for the mutant allele G (5' GTG GGA GGC AGA CAG CTG 3'). In both cases, the amplicon size was 175 bp. Reaction conditions and usage of internal controls, adopted from phototyping methodology, are also described elsewhere [16].
###end p 13
###begin title 14
2.3. Statistics
###end title 14
###begin p 15
###xml 46 49 46 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 226 229 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 294 295 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 436 438 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 609 611 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 182 189 <span type="species:ncbi:9606">patient</span>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
Hardy-Weinberg equilibrium was tested using a chi2 test of observed and expected genotype frequencies. Differences between allelic, genotype, and phenotype (carriage) frequencies in patient and control groups were assessed by chi2 test using Woolf-Haldane correction in cases of small numbers. P value <.05 was considered to be significant. Statistical power of the present study to replicate main result from the initial German study [13] (the difference between the proportion of MCP-1 -2518 GG homozygotes in SSc patients and control subjects) was determined according to the protocol described elsewhere [17].
###end p 15
###begin title 16
3. RESULTS
###end title 16
###begin p 17
###xml 134 141 134 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 243 250 <span type="species:ncbi:9606">patient</span>
Distribution of alleles, genotypes, and phenotypes of MCP-1 -2518 A/G SNP in patients with SSc and control population is presented in Table 2. The distribution of MCP-1 -2518 genotypes was in compliance with Hardy-Weinberg equilibrium in both patient and control groups (P > .05). Statistical power of present study to replicate observations originally reported for the German population [13] reached 99%.
###end p 17
###begin p 18
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 289 290 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 250 258 <span type="species:ncbi:9606">patients</span>
No significant differences in distribution of MCP-1 -2518*G allele were observed between patients with SSc and healthy controls (P > .05). Furthermore, MCP-1 -2518 GG homozygotes and MCP-1 -2518*G allele carriers were similarly represented among SSc patients and healthy control subjects (P > .05).
###end p 18
###begin p 19
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 761 762 761 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 770 777 770 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 925 932 925 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 996 997 996 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1005 1012 1005 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 259 267 <span type="species:ncbi:9606">patients</span>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 492 500 <span type="species:ncbi:9606">patients</span>
###xml 617 625 <span type="species:ncbi:9606">patients</span>
###xml 665 673 <span type="species:ncbi:9606">patients</span>
###xml 844 852 <span type="species:ncbi:9606">patients</span>
###xml 1046 1054 <span type="species:ncbi:9606">patients</span>
Because different phenotypes of SSc have been recently thought not to necessarily share a common genetic background [4], we were further interested if MCP-1 -2518 A/G variants may be related to internal organ involvement or limited/diffuse form of SSc in our patients. The GG genotype was associated with GI affliction (P = .007), when the distribution of MCP-1 -2518 A/G SNP was compared between the patients with GI involvement and healthy controls. The allele and phenotype frequencies in patients with the GI affliction or the diffuse form of SSc did not differ from those in healthy controls (P > .05). When the patients with GI involvement were compared with patients without the affliction, we found no difference in the distribution of MCP-1 -2518 SNP (P > .05, Table 3). Furthermore, the allele, genotype, and phenotype frequencies in patients with limited SSc were similar to those observed in diffuse form of SSc (Table 3). Similarly, MCP-1 -2518 SNP was not related to the pulmonary (P > .05, Table 3) or renal involvement in our SSc patients (data not shown).
###end p 19
###begin title 20
4. DISCUSSION
###end title 20
###begin p 21
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Despite an adequate methodical approach, the present study did not reveal an association between MCP-1 -2518 A/G single nucleotide polymorphism and systemic sclerosis in Slovak population. Therefore, our data do not confirm the findings from German population [13] and do not support hypothesis that MCP-1 -2518 A/G SNP is directly involved in the genetic susceptibility to SSc.
###end p 21
###begin p 22
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
To explore the association of MCP-1 -2518 A/G SNP with susceptibility for SSc, our case-control study used the same methodological strategy as the original report [13], but importantly the size of the case group in our study was 2.5 fold bigger than the original one (46 versus 18). Moreover, the statistical power of the current study to replicate the initial observation reaches 99%. This value is sufficiently high in order to detect the genetic association described in original study, because it exceeds 80% threshold [17].
###end p 22
###begin p 23
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
One may argue that discrepant observations in North-European and Eastern-European populations may be due to different ethnic background. However, there were no differences in frequencies of the MCP-1 -2518 G allele and also of GG homozygote between German and Slovak healthy populations and further, these were similar to those reported in other Caucasian populations [13, 18]. In this regard, Slavonic and German populations also did not differ in the distribution of a spectrum of twenty-two cytokine SNPs located across 1, 2, 4, 5, 6, 7, 12, 16, and 19 chromosomes [19, 20].
###end p 23
###begin p 24
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 614 615 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
###xml 362 369 <span type="species:ncbi:9606">patient</span>
###xml 457 465 <span type="species:ncbi:9606">patients</span>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
Since patients in both centres were enrolled according to unified international criteria, it is improbable that discrepancies between these two studies were caused by heterogeneous disease phenotypes. In our opinion, the most straightforward explanation of the positive genetic association reported in the original study may be the very small sample size of its patient group (n = 18) that may not reflect real distribution of MCP-1 -2518 A/G SNP in German patients [13]. In support of this explanation, also a recent study investigating a spectrum of chemokine polymorphisms in non-Caucasian (Korean) population [2] included more SSc patients than the original German study [13] and similar to us, no relationship between the MCP-1 A/G SNP and disease in Koreans was observed [2].
###end p 24
###begin p 25
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
###xml 565 573 <span type="species:ncbi:9606">patients</span>
###xml 701 709 <span type="species:ncbi:9606">patients</span>
Despite the number of SSc patients in our study was much higher than in original report [13], in one particular situation it may be considered as "suboptimal:" our study may not be powerful enough to detect possible "true association" in case that it would be much weaker than observed in initial German study [13]. This situation could occur if this MCP-1 polymorphism confers a risk to only particular phenotype of SSc that is overpresented in German patients [13], but minor or totally absent in Slovak patients group. In this regard, German study recruited SSc patients presenting with skin involvement while affection of other internal organs was not reported here [13] by contrast to our Slovak patients. Taking this into account, we can speculate that MCP-1 -2518 A/G SNP may be related to a particular phenotype of SSc.
###end p 25
###begin p 26
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
Finally, from a geneticist's point of view, the contradiction between the present study and the initial observations [13] can be explained by the presence of linkage disequilibrium (LD). Although MCP-1 -2518 A/G has been the most commonly investigated MCP-1 SNP, there are other SNPs located in the MCP-1 gene [12]. Moreover, the data on the functional significance of MCP-1 -2518 A/G SNP are not consistent [13, 16], and the investigated SNP is not the only factor involved in regulation of MCP-1 gene transcriptional activity [12]. It may be, therefore, speculated that in setting of systemic sclerosis, the MCP-1 -2518*G allele represents a marker in linkage disequilibrium (LD) with supposed "casual" allele located nearby. In this context, the investigations of the role for MCP-1 gene polymorphisms should be directed at wider range of SNPs and take into account haplotype combinations [12].
###end p 26
###begin p 27
In conclusion, this case-control study performed in Slovak population does not provide further evidence for recently formulated concept that MCP-1 -2518 A/G SNP is involved in the genetic predisposition to systemic sclerosis as a whole. However, it remains to be elucidated whether MCP-1 -2518 A/G SNP may be in linkage disequilibrium with a causative variant conferring susceptibility to SSc, which may be located within the polymorphic CC chemokine genetic cluster on the chromosome 17.
###end p 27
###begin title 28
ACKNOWLEDGMENTS
###end title 28
###begin p 29
Authors acknowledge the technical help of J. Onderkova and S. Zachova. This work was supported in part by the Grant Agency of Czech Republic (GACR310/05/2614) and the Czech government (MSYCR-MSM6198959205). The findings of this study were partially presented at 1st Joint Meeting of European National Society of Immunology and 16th European Congress of Immunology, 6-9 September 2006, Paris, France.
###end p 29
###begin article-title 30
Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays
###end article-title 30
###begin article-title 31
Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis
###end article-title 31
###begin article-title 32
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1B</italic>
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL2</italic>
Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis
###end article-title 32
###begin article-title 33
Epidemiology and classification of scleroderma
###end article-title 33
###begin article-title 34
Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement
###end article-title 34
###begin article-title 35
Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis
###end article-title 35
###begin article-title 36
Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis
###end article-title 36
###begin article-title 37
Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression
###end article-title 37
###begin article-title 38
###xml 110 115 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 122 127 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 138 142 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 196 201 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Augmented production of chemokines (monocyte chemotactic protein-1 (MCP- 1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis
###end article-title 38
###begin article-title 39
Pathogenic role of CCL2/MCP-1 in scleroderma
###end article-title 39
###begin article-title 40
###xml 46 51 <span type="species:ncbi:9606">human</span>
MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes
###end article-title 40
###begin article-title 41
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCL2</italic>
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study
###end article-title 41
###begin article-title 42
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis
###end article-title 42
###begin article-title 43
Replication validity of genetic association studies
###end article-title 43
###begin article-title 44
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
###end article-title 44
###begin article-title 45
The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population
###end article-title 45
###begin article-title 46
Power and replication in case-control studies
###end article-title 46
###begin article-title 47
A monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation
###end article-title 47
###begin article-title 48
Distribution of 22 cytokine gene polymorphisms in the healthy Czech population
###end article-title 48
###begin article-title 49
Single nucleotide polymorphisms of cytokine genes in the healthy Slovak population
###end article-title 49
###begin p 50
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of 46 patients with systemic sclerosis.
###end p 50
###begin p 51
###xml 0 0 0 0 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
*In 2 patients the information is not available.
###end p 51
###begin p 52
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Genotype, allele, and phenotype (carriage rates) frequencies of the MCP-1 -2518 SNP in Slovak patients with systemic sclerosis and healthy controls compared with the data from German population according to the study by Karrer et al. [13].
###end p 52
###begin p 53
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 254 255 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 365 377 365 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#167;</sup>
###xml 377 378 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 386 387 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 481 483 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 486 492 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 492 493 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
Data are given as proportions (%) of particular genotype/allele/phenotype with their absolute number in parentheses. P values for comparison of allele, genotype, and phenotype frequencies between the Slovak SSc patients and controls: +P = .81; *P = .67; #P = .51. P value for comparison of GG genotype frequencies between the German SSc patients and controls [13]: section signP = .02. P value for comparison of G allele frequencies between the Slovak and German control subjects [13]: daggerP = .23.
###end p 53
###begin p 54
###xml 104 112 <span type="species:ncbi:9606">patients</span>
Genotype, allele, and phenotype (carriage rates) frequencies of the MCP-1 -2518 SNP in the subgroups of patients with systemic sclerosis (SSc) according to the particular clinical manifestation of the disease (diffuse versus limited form, presence versus absence of lung or gastrointestinal (GI) involvements).
###end p 54
###begin p 55
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are given as proportions (%) of particular genotype/allele/phenotype with their absolute number in parentheses. P >/= .05 for diffuse versus limited form of SSc and presence versus absence of lung or gastrointestinal (GI) involvements.
###end p 55

